- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Astec LifeSciences Limited — Updates, 31-07-2026: Press Release
31-07-2026 | 08:52 pm
31-07-2026 | 08:52 pm
Astec LifeSciences reported Q1FY27 consolidated total income of ₹84.3 Cr, down 8%. Despite lower revenue, the company achieved EBITDA breakeven at ₹0.1 Cr, reducing loss to ₹18.7 Cr. This improvement was driven by a favorable product mix and enhanced capacity utilization.
No comments yet. Be the first to comment!